Bonnie Anderson is Founder & CEO of PinkDx and Co-Founder, Chairman of the Board and CEO of Veracyte, a global genomic diagnostics company that improves patient care by informing diagnosis and treatment decisions in cancer and other diseases. Before Veracyte, Ms. Anderson spent 18 years at Beckman Coulter, where she held leadership positions across the global life sciences and diagnostic business segments, including flow cytometry. After she retired from Beckman Coulter, Ms. Anderson was brought into a life sciences incubator formed by Kleiner Perkins, Versant Ventures and TPG Biotech, where she developed the concept for Veracyte. Veracyte is now a public global company with a market capitalization of nearly $2 billion.